AstraZeneca has completed the resurrection of its anifrolumab drug for systemic lupus erythematosus (SLE ... but bounced back with positive data from a second study – TULIP-2 – that has ...
Hosted on MSN6mon
Biogen and Belgian partner UCB announce positive data from late-stage trial of lupus treatmentBiogen Inc.’s stock was slightly lower Tuesday, shedding early gains made after the company and Belgian partner UCB announced positive results in a late-stage trial of a treatment for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback